TY - JOUR
T1 - Genotype-phenotype correlation in 22q11.2 deletion syndrome
AU - Michaelovsky, Elena
AU - Frisch, Amos
AU - Carmel, Miri
AU - Patya, Miriam
AU - Zarchi, Omer
AU - Green, Tamar
AU - Basel-Vanagaite, Lina
AU - Weizman, Abraham
AU - Gothelf, Doron
N1 - Funding Information:
This project was funded by the March of Dimes grant # 5-FY06-590 (to D.G. and A.F.). The funding body had no role in study design, data collection, analysis and interpretation of data, writing of the manuscript and the decision to submit it. The departments and institutions where the work was done: Felsenstein Medical Research Center, Petah Tikva, Israel and the Behavioral Neurogenetics Center, Sheba Medical Center.
PY - 2012/12/17
Y1 - 2012/12/17
N2 - Background: The 22q11.2 deletion syndrome (22q11.2DS) is caused by hemizygous microdeletions on chromosome 22q11.2 with highly variable physical and neuropsychiatric manifestations. We explored the genotype-phenotype relationship in a relatively large 22q11.2DS cohort treated and monitored in our clinic using comprehensive clinical evaluation and detailed molecular characterization of the deletion.Methods: Molecular analyses in 142 subjects with 22q11.2DS features were performed by FISH and MLPA methods. Participants underwent clinical assessment of physical symptoms and structured psychiatric and cognitive evaluation.Results: Deletions were found in 110 individuals including one with an atypical nested distal deletion which was missed by the FISH test. Most subjects (88.2%) carried the 3Mb typically deleted region and 11.8% carried 4 types of deletions differing in size and location. No statistically significant genotype-phenotype correlations were found between deletion type and clinical data although some differences in hypocalcemia and cardiovascular anomalies were noted.Analysis of the patient with the distal nested deletion suggested a redundancy of genes causing the physical and neuropsychiatric phenotype in 22q11.2DS and indicating that the psychiatric and cognitive trajectories may be governed by different genes.Conclusions: MLPA is a useful and affordable molecular method combining accurate diagnosis and detailed deletion characterization. Variations in deletion type and clinical manifestations impede the detection of significant differences in samples of moderate size, but analysis of individuals with unique deletions may provide insight into the underlying biological mechanisms.Future genotype-phenotype studies should involve large multicenter collaborations employing uniform clinical standards and high-resolution molecular methods.
AB - Background: The 22q11.2 deletion syndrome (22q11.2DS) is caused by hemizygous microdeletions on chromosome 22q11.2 with highly variable physical and neuropsychiatric manifestations. We explored the genotype-phenotype relationship in a relatively large 22q11.2DS cohort treated and monitored in our clinic using comprehensive clinical evaluation and detailed molecular characterization of the deletion.Methods: Molecular analyses in 142 subjects with 22q11.2DS features were performed by FISH and MLPA methods. Participants underwent clinical assessment of physical symptoms and structured psychiatric and cognitive evaluation.Results: Deletions were found in 110 individuals including one with an atypical nested distal deletion which was missed by the FISH test. Most subjects (88.2%) carried the 3Mb typically deleted region and 11.8% carried 4 types of deletions differing in size and location. No statistically significant genotype-phenotype correlations were found between deletion type and clinical data although some differences in hypocalcemia and cardiovascular anomalies were noted.Analysis of the patient with the distal nested deletion suggested a redundancy of genes causing the physical and neuropsychiatric phenotype in 22q11.2DS and indicating that the psychiatric and cognitive trajectories may be governed by different genes.Conclusions: MLPA is a useful and affordable molecular method combining accurate diagnosis and detailed deletion characterization. Variations in deletion type and clinical manifestations impede the detection of significant differences in samples of moderate size, but analysis of individuals with unique deletions may provide insight into the underlying biological mechanisms.Future genotype-phenotype studies should involve large multicenter collaborations employing uniform clinical standards and high-resolution molecular methods.
KW - Copy number variation (CNV)
KW - Molecular diagnosis
KW - Multiplex ligation probe amplification (MLPA)
KW - Neuropsychiatric disorders
KW - Velocardiofacial syndrome (VCFS)
UR - http://www.scopus.com/inward/record.url?scp=84870985438&partnerID=8YFLogxK
U2 - 10.1186/1471-2350-13-122
DO - 10.1186/1471-2350-13-122
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
AN - SCOPUS:84870985438
SN - 1471-2350
VL - 13
JO - BMC Medical Genetics
JF - BMC Medical Genetics
M1 - 122
ER -